Difference between revisions of "Pentamidine (Nebupent)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
(One intermediate revision by the same user not shown) | |||
Line 17: | Line 17: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
− | [[Category: | + | [[Category:Inhalation medications]] |
[[Category:Antifungals]] | [[Category:Antifungals]] | ||
[[Category:PCP prophylaxis]] | [[Category:PCP prophylaxis]] | ||
− | [[Category: | + | [[Category:FDA approved in 1989]] |
Revision as of 19:36, 30 July 2018
General information
Class/mechanism: Antifungal, known to have activity against Pneumocystis jiroveci. Mechanism not fully understood, but mechanism hypothesized to involve inhibition of DNA, RNA, phospholipid, and protein synthesis.[1][2]
Route: inhaled, IM, IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
Also known as
- Generic name: pentamidine dimesilate
- Brand names: Benambax, Lomidine, Nebupent, Pentam, Pentamidina, Pneumopent